Cargando…

Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer

Bladder cancer is the second most common urological malignancy in the world. In 70% of cases it is initially diagnosed as non-muscle-invasive bladder cancer (NMIBC) and it is amenable to local treatments, with intravesical (IVES) Bacillus-Calmette-Guerin (BCG) immunotherapy being routinely used afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hojeij, Rim, Domingos-Pereira, Sonia, Nkosi, Marianne, Gharbi, Dalila, Derré, Laurent, Schiller, John T., Jichlinski, Patrice, Nardelli-Haefliger, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964499/ https://www.ncbi.nlm.nih.gov/pubmed/27428950 http://dx.doi.org/10.3390/ijms17071125

Ejemplares similares

Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)

Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012)

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
por: Pieraerts, Claire, et al.
Publicado: (2012)

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013)

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
por: Domingos-Pereira, Sonia, et al.
Publicado: (2022)

Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion
por: Alonso, Florian, et al.
Publicado: (2016)

What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012)

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
por: Nguyen, Sylvain, et al.
Publicado: (2022)

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Benmerzoug, Sulayman, et al.
Publicado: (2021)

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
por: Lucca, Ilaria, et al.
Publicado: (2022)

Double Positive CD4(+)CD8(+) T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
por: Bohner, Perrine, et al.
Publicado: (2019)

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model
por: Domingos-Pereira, Sonia, et al.
Publicado: (2021)

Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
por: Domingos-Pereira, Sonia, et al.
Publicado: (2019)

Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles
por: Kines, Rhonda C., et al.
Publicado: (2015)

Mucosal Delivery of Human Papillomavirus Pseudovirus-Encapsidated Plasmids Improves Potency of DNA Vaccination
por: Graham, Barney S., et al.
Publicado: (2010)

Characterization of human papillomavirus type 16 pseudovirus containing histones
por: Kim, Hyoung Jin, et al.
Publicado: (2016)

Optimization of human papillomavirus-based pseudovirus techniques for efficient gene transfer
por: Gilson, Timra D., et al.
Publicado: (2020)

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses
por: Brendle, Sarah, et al.
Publicado: (2021)

Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth
por: Sathiyanadan, Karthik, et al.
Publicado: (2022)

Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity
por: Xia, Ming, et al.
Publicado: (2022)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman
por: Valerio, Massimo, et al.
Publicado: (2011)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Pseudoviruses for the assessment of coronavirus disinfection by ozone
por: Zucker, Ines, et al.
Publicado: (2021)

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera
por: Draper, Eve, et al.
Publicado: (2011)

SITC 26(th) annual meeting – summary
por: Romano, Emanuela, et al.
Publicado: (2012)

HIV-1 pseudoviruses constructed in China regulatory laboratory
por: Nie, Jianhui, et al.
Publicado: (2019)

Teicoplanin inhibits Ebola pseudovirus infection in cell culture
por: Wang, Yizhuo, et al.
Publicado: (2016)

Preparation and application of chikungunya pseudovirus containing double reporter genes
por: Su, Chunyan, et al.
Publicado: (2022)

Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
por: Desheva, Yulia, et al.
Publicado: (2023)

Targeted knock-ins with pseudovirus for the stable expression of large transgenes
Publicado: (2023)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
por: Lang, Jianshe, et al.
Publicado: (2011)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of Apc(Min/+) mice
por: Zhong, Zhenyu, et al.
Publicado: (2017)

Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles
por: Burnie, Jonathan, et al.
Publicado: (2020)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0r74pm7gtmjc3tiklnah09mskg